The latest on cardiometabolic disease and Covid-19
Prevalence and contamination risk associated with Diabetes, a meta-analysis
Management of critically ill adults, a guideline summary for practioners
Hydroxychloroquine/Azithromycin combination and QTc, an expert recommendation
D-Dimer associated with severity, a pooled analysis
Effect of coronaviruses on the cardiovascular system, a systematic review
COVID-19 and cardiovascular disease, a narrative review
Nomogram for early prediction of risk, a multicenter retrospective study
COVID-19 and the cardiovascular system, a review of the literature
Cardiovascular implications in fatality, a retrospective monocentric study
Experimental treatments and controversies, a review
Heparin and mortality in patients with coagulopathy, a retrospective cohort study
Early use of short term corticosteroids therapy, an open-label non-randomized monocentric trial
Clinical features associated with fatality, a retrospective cohort study
Anti-inflammatory drugs and severe cases, a review, and expert position from China
CFR and characteristics linked to fatality, a short summary of Italian cases
Clinical features in severe pediatric patients with COVID-19, An observational study
Withdrawing renin-angiotensin inhibitors in COVID-19? A short review of the literature
Outcomes in severely ill patients, a multicentric retrospective cohort study (50 US states)
On Ibuprofen-associated risk during COVID-19, a news story
Liver injury and severe coronavirus infections, a summary of the evidence